NORTHWEST BIOTHERAPEUTICS INC Contracts & Agreements

Loan Agreement, dated March 2, 2023, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on March 5, 2024)

Loan Agreement, dated November 10, 2023, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on March 5, 2024)

Loan Agreement, dated September 26, 2022, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on February 28, 2023)

Loan Agreement, dated November 22, 2021, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on March 1, 2022)

Sub-lease Agreement, dated December 31, 2021, by and between Aracaris Ltd. and Northwest Biotherapeutics, Inc. (collectively the Sub-Lessor) and Advent BioServices, Ltd. (the... (Filed With SEC on March 1, 2022)

Description of Securities (Filed With SEC on March 31, 2021)

Equity Compensation Plan, dated May 29, 2020 (Filed With SEC on March 31, 2021)

Note and Loan Agreement, dated August 14, 2021, by and between Northwest Biotherapeutics, Inc. and Iliad Research and Trading L.P (Filed With SEC on March 31, 2021)

Agreement to acquire Flaskworks, L.L.C, August 28, 2020 (Filed With SEC on March 31, 2021)

Loan Agreement, dated March 1, 2021, by and between Northwest Biotherapeutics, Inc. and Streeterville Capital, L.L.C (Filed With SEC on March 31, 2021)

Description of Securities (Filed With SEC on March 16, 2020)

Settlement and Amendment Agreement (2016 Obligations Agreement), dated as of December 31, 2017, by and between Northwest Biotherapeutics, Inc. and Cognate BioServices, Inc (Filed With SEC on April 2, 2019)

Settlement and Amendment Agreement (2017 Obligations Agreement), dated as of December 31, 2017, by and between Northwest Biotherapeutics, Inc. and Cognate BioServices, Inc (Filed With SEC on April 2, 2019)

Note and Loan Agreement, dated as of March 14, 2018, by and between Northwest Biotherapeutics, Inc. and Linda F. Powers (Filed With SEC on April 2, 2019)

Note and Loan Agreement, dated as of March 19, 2018, by and between Northwest Biotherapeutics, Inc. and Linda F. Powers (Filed With SEC on April 2, 2019)

Promissory Note in the principal amount of $1,388,888.89, dated as of May 1, 2018, by and between Northwest Biotherapeutics, Inc. and Adar Bays, LLC (Filed With SEC on April 2, 2019)

Form of Loan Agreement, dated as of November 7, 2018, by and between Northwest Biotherapeutics, Inc. and a Group of Private Lenders (Filed With SEC on April 2, 2019)

Contract Relating to Sale of Spicers, Sawston, Cambridge, dated as of December 5, 2018, by and between Aracaris Capital Limited and Huawei Technologies Research & Development (UK)... (Filed With SEC on April 2, 2019)

Lease Relating to Vision Centre, Sawston, Cambridge, by and between Aracaris Capital Limited and Aracaris Limited, dated as of December 14, 2018 (Filed With SEC on April 2, 2019)

Form of Securities Purchase Agreement, dated June 22, 2017, by and between Northwest Biotherapeutics, Inc. and certain purchasers (Filed With SEC on June 28, 2018)

Form of Class D-3 Common Stock Purchase Warrant (Filed With SEC on June 28, 2018)

Sawton Lease, dated October 10, 2017 (Filed With SEC on April 17, 2018)

Form of Class D-2 Common Stock Purchase Warrant (Filed With SEC on January 4, 2018)

Form of Voting Agreement (Filed With SEC on January 4, 2018)

Form of Subscription Agreement (Filed With SEC on January 4, 2018)

Form of Class D-1 Common Stock Purchase Warrant (Filed With SEC on December 7, 2017)

Form of Voting Agreement (Filed With SEC on December 7, 2017)

Form of Subscription Agreement (Filed With SEC on December 7, 2017)

Form of Securities Purchase Agreement, dated September 20, 2017, by and between Northwest Biotherapeutics, Inc. and certain institutional investors (Filed With SEC on September 22, 2017)

Form of Class A Common Stock Purchase Warrant (Filed With SEC on September 22, 2017)

Engagement Agreement with Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC (Filed With SEC on September 22, 2017)

NORTHWEST BIOTHERAPEUTICS,INC. LOAN AGREEMENT and PROMISSORY NOTE (Filed With SEC on August 21, 2017)

[Holder signature page follows] (Filed With SEC on August 7, 2017)

COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on August 7, 2017)

SECURITIESEXCHANGE AGREEMENT (Filed With SEC on June 27, 2017)

NOTEPURCHASE AGREEMENT (Filed With SEC on June 27, 2017)

NORTHWEST BIOTHERAPEUTICS,INC. SECOND SUPPLEMENTAL INDENTURE (Filed With SEC on June 13, 2017)

SECURITIESEXCHANGE AGREEMENT (Filed With SEC on May 31, 2017)

NORTHWEST BIOTHERAPEUTICS,INC. FIRST SUPPLEMENTAL INDENTURE (Filed With SEC on March 23, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 23, 2017)

CLASS A COMMON STOCK PURCHASE WARRANT NORTHWESTBIOTHERAPEUTICS, INC. (Filed With SEC on March 23, 2017)

CLASS B COMMON STOCK PURCHASE WARRANT NORTHWESTBIOTHERAPEUTICS, INC. (Filed With SEC on March 23, 2017)

CLASS C COMMON STOCK PURCHASE WARRANT NORTHWESTBIOTHERAPEUTICS, INC. (Filed With SEC on March 23, 2017)

430 Park Avenue | New York, New York 10022 | 212 ###-###-#### Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC (Filed With SEC on March 23, 2017)

Annex A (Filed With SEC on September 19, 2016)

SERIES E COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on September 19, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 19, 2016)

430 Park Avenue | New York, New York 10022 | 212 ###-###-#### | www.hcwco.com Member: FINRA/SIPC (Filed With SEC on September 19, 2016)

EXCHANGE AGREEMENT (Filed With SEC on September 6, 2016)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 11, 2016)

COMMON STOCK PURCHASE WARRANT NORTHWESTBIOTHERAPEUTICS, INC. (Filed With SEC on July 11, 2016)

NORTHWESTBIOTHERAPEUTICS, INC. PLACEMENT AGENCY AGREEMENT (Filed With SEC on July 11, 2016)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 3, 2016)

SERIES [A/B/C] COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on March 3, 2016)

430 Park Avenue | New York,New York 10022 | 212 ###-###-#### | www.hcwco.com Member: FINRA/SIPC (Filed With SEC on March 3, 2016)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on December 29, 2015)

COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on December 29, 2015)

430Park Avenue | New York, New York 10022 | 212 ###-###-#### | www.hcwco.com Member:FINRA/SIPC (Filed With SEC on December 29, 2015)

[Remainder of pageintentionally left blank] (Filed With SEC on December 29, 2015)

NORTHWESTBIOTHERAPEUTICS, INC. STOCKPURCHASE AGREEMENT (Filed With SEC on October 23, 2015)

NORTHWEST BIOTHERAPEUTICS,INC. STOCK PURCHASE AGREEMENT (Filed With SEC on April 8, 2015)

COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on October 10, 2014)

STOCK PURCHASE, AMENDMENT AND ISSUANCEAGREEMENT (Filed With SEC on October 10, 2014)

[remainder of page intentionallyblank] (Filed With SEC on October 10, 2014)

NORTHWEST BIOTHERAPEUTICS, INC., and TheBank of New York Mellon, as Trustee INDENTURE Dated as of August 19, 2014 5.00% Convertible Senior Notes due 2017 (Filed With SEC on August 25, 2014)

PLEDGE AND ESCROW AGREEMENT (Filed With SEC on August 25, 2014)

NORTHWEST BIOTHERAPEUTICS, INC. 5.00% Convertible Senior Notes due 2017 Purchase Agreement (Filed With SEC on August 19, 2014)

*Portions of this exhibit marked [*] arerequested to be treated confidentially. DCVAX®-L MANUFACTURING AND SERVICESAGREEMENT (Filed With SEC on May 15, 2014)

*Portions of this exhibit marked [*] are requestedto be treated confidentially. DCVAX-DIRECT MANUFACTURING AND SERVICESAGREEMENT (Filed With SEC on May 15, 2014)

*Portions of this exhibit marked [*] arerequested to be treated confidentially. ANCILLARY SERVICES AGREEMENT (Filed With SEC on May 15, 2014)

MANUFACTURING EXPANSION SERVICES AGREEMENT (Filed With SEC on May 15, 2014)

COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on April 14, 2014)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on April 14, 2014)

430 Park Avenue | New York,New York 10022 | 212 ###-###-#### | www.hcwco.com Member: FINRA/SIPC (Filed With SEC on April 14, 2014)

4,895,834 Shares NORTHWEST BIOTHERAPEUTICS, INC. Common Stock and Warrants to Purchase up to 2,447,917Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 20, 2013)

COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on November 20, 2013)

LONG TERM COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on August 9, 2013)

OVER-ALLOTMENT COMMON STOCK PURCHASEWARRANT northwestbiotherapeutics, inc. (Filed With SEC on August 9, 2013)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on August 9, 2013)

NORTHWEST BIOTHERAPEUTICS, INC. PLACEMENT AGENT AGREEMENT (Filed With SEC on August 9, 2013)

COMMON STOCK PURCHASE WARRANT northwestbiotherapeutics, inc. (Filed With SEC on April 22, 2013)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on April 22, 2013)

H.C. Wainwright & Co., LLC Established 1868 (Filed With SEC on April 22, 2013)

UNDERWRITING AGREEMENT between NORTHWEST BIOTHERAPEUTICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on December 4, 2012)

NORTHWEST BIOTHERAPEUTICS, INC. WARRANTAGENCY AGREEMENT (Filed With SEC on December 4, 2012)

UNDERWRITING AGREEMENT between NORTHWEST BIOTHERAPEUTICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on November 15, 2012)

MARNIX BOSCH: EMPLOYMENT AGREEMENT (Filed With SEC on November 15, 2012)

ALTON BOYNTON: EMPLOYMENT AGREEMENT (Filed With SEC on November 15, 2012)

ANTHONY MAIDA: EMPLOYMENT AGREEMENT (Filed With SEC on November 15, 2012)

LESLIE J. GOLDMAN : EMPLOYMENT AGREEMENT (Filed With SEC on November 15, 2012)

LINDA F. POWERS : EMPLOYMENT AGREEMENT (Filed With SEC on November 15, 2012)

SERVICES AGREEMENT (Filed With SEC on June 29, 2012)

AMENDMENT NO. 2 TO PURCHASE AGREEMENT (Filed With SEC on January 10, 2012)

PURCHASE AGREEMENT (Filed With SEC on December 23, 2011)

AMENDMENT NO. 1 TO PURCHASE AGREEMENT (Filed With SEC on December 23, 2011)

CONVERSIONAGREEMENT (Filed With SEC on November 23, 2009)

FORMOF LOAN AGREEMENT and PROMISSORY NOTE EXTENSIONAGREEEMENT (Filed With SEC on November 23, 2009)

RETENTION AND CONVERSIONAGREEMENT (Filed With SEC on November 23, 2009)

NORTHWESTBIOTHERAPEUTICS, INC. FORMOF LOAN AGREEMENT and PROMISSORYNOTE (Filed With SEC on April 15, 2009)

NORTHWESTBIOTHERAPEUTICS, INC. (Filed With SEC on April 15, 2009)

NORTHWESTBIOTHERAPEUTICS FORMof SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 15, 2009)

NORTHWESTBIOTHERAPEUTICS, INC. FORMof WARRANT (Filed With SEC on April 15, 2009)

NORTHWESTBIOTHERAPEUTICS, INC. FORMOF LOAN AGREEMENT and FORMOF PROMISSORY NOTE (Filed With SEC on April 15, 2009)

Current assets (Filed With SEC on November 19, 2008)

NORTHWEST BIOTHERAPEUTICS, INC. LOAN AGREEMENT and PROMISSORY NOTE US $4 million May 6, 2008 (Filed With SEC on May 15, 2008)

SUBLEASE AGREEMENT (Filed With SEC on March 24, 2008)

Northwest ###-###-#### www.nwbio.comBiotherapeutics, Inc. (800)-519-0755 OTCBB: NWBO f ###-###-#### 18701 120th Avenue NE Suite 101 Bothell, WA 98011 (Filed With SEC on October 2, 2007)

CONVERSION AGREEMENT (Filed With SEC on June 22, 2007)

TERMINATION AGREEMENT (Filed With SEC on June 22, 2007)

NORTHWEST BIOTHERAPEUTICS, INC. (Filed With SEC on June 22, 2007)

DATED JUNE 2007 (Filed With SEC on June 22, 2007)

Northwest Biotherapeutics, Inc. 2007 Stock Option Plan Approved By Board: April 15, 2007 Effective Date: April 22, 2007 Approved By Stockholders: , 2007 Termination Date: April... (Filed With SEC on June 22, 2007)

Northwest ###-###-#### www.nwbio.com Biotherapeutics, Inc. (800) 519-0755 OTCBB: NWBT f ###-###-#### 18701 120th Avenue NE Suite 101 Bothell, WA 98011 (Filed With SEC on June 22, 2007)

Northwest Biotherapeutics, Inc. 18701 120th Avenue NE Suite 101 Bothell, WA 98011 ###-###-#### ###-###-#### f ###-###-#### www.nwbio.com OTCBB: NWBT (Filed With SEC on June 22, 2007)

DEMAND NOTE $225,000.00 Bothell, Washington June 13, 2007 (Filed With SEC on June 18, 2007)

FORMOF NORTHWEST BIOTHERAPEUTICS, INC. LOAN AGREEMENT and 10% CONVERTIBLE PROMISSORY NOTE $[ ] June 1, 2007 (Filed With SEC on June 7, 2007)

NORTHWEST BIOTHERAPEUTICS, INC. (Filed With SEC on June 7, 2007)

LETTER OF AGREEMENT by and between The INTERNATIONAL UNION of OPERATING ENGINEERS LOCAL 302 and NW BIOTHERAPEUTICS (Tenant) (Filed With SEC on June 4, 2007)

Northwest Biotherapeutics DCVax-Brain Services Agreement To: Northwest Biotherapeutics Agreement #: 051407-118701 120th Avenue NE, Suite 101 Bothell, WA 98011 Date: 5/17/07Phone... (Filed With SEC on May 21, 2007)

Entry Into a Material Definitive Agreement (Filed With SEC on May 3, 2007)

the issuance of a series of convertible promissory notes to Toucan Capital Fund II, L.P. (Toucan Capital), a venture capital fund, in aggregate principal amount of approximately... (Filed With SEC on April 17, 2007)

the issuance of a series of convertible promissory notes to Toucan Capital Fund II, L.P. (Toucan Capital), a venture capital fund, in aggregate principal amount of approximately... (Filed With SEC on April 18, 2006)

Current assets (Filed With SEC on November 14, 2005)

Alton L. Boynton, Ph.D (Filed With SEC on August 1, 2005)

Amendment No. 6 to the Amended and Restated Recapitalization Agreement between Northwest Biotherapeutics, Inc. and Toucan Capital Fund II, L.P., dated May 13, 2005 (Filed With SEC on May 18, 2005)

Loan Principal (Filed With SEC on April 15, 2005)

Amendment No. 3 to the Amended and Restated Recapitalization Agreement between Northwest Biotherapeutics, Inc. and Toucan Capital Fund II, L.P., dated December 27, 2004 (Filed With SEC on December 30, 2004)

NORTHWEST BIOTHERAPEUTICS, INC (Filed With SEC on June 22, 2004)

Type Of Cancer (Filed With SEC on May 14, 2004)

PART I FINANCIAL INFORMATION (Filed With SEC on November 14, 2003)

PART I FINANCIAL INFORMATION (Filed With SEC on August 14, 2003)

PART I FINANCIAL INFORMATION (Filed With SEC on May 14, 2003)

Assignment and License Agreement, effective as of December 9, 2002, between Medarex Inc., Northwest Biotherapeutics, Inc. and Genpharm International, Inc. (Certain confidential... (Filed With SEC on December 23, 2002)

Category

Industry

Companies

Contracts

NORTHWEST BIOTHERAPEUTICS INC Contracts & Agreements